WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 38 filers reported holding WEREWOLF THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,150,045 | -29.8% | 6,144,881 | 0.0% | 0.26% | -26.8% |
| Q2 2023 | $18,741,887 | +17.3% | 6,144,881 | 0.0% | 0.35% | -2.2% |
| Q1 2023 | $15,976,691 | +81.6% | 6,144,881 | +43.2% | 0.36% | +103.4% |
| Q4 2022 | $8,798,356 | -54.5% | 4,291,881 | 0.0% | 0.18% | -56.9% |
| Q3 2022 | $19,356,000 | +10.3% | 4,291,881 | 0.0% | 0.41% | -11.8% |
| Q2 2022 | $17,554,000 | -7.0% | 4,291,881 | 0.0% | 0.47% | +13.6% |
| Q1 2022 | $18,884,000 | -63.1% | 4,291,881 | 0.0% | 0.41% | -54.3% |
| Q4 2021 | $51,116,000 | -30.6% | 4,291,881 | 0.0% | 0.90% | -11.8% |
| Q3 2021 | $73,649,000 | -1.6% | 4,291,881 | 0.0% | 1.02% | -15.0% |
| Q2 2021 | $74,850,000 | – | 4,291,881 | – | 1.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $1,531,665 | 35.68% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $11,138,847 | 4.64% |
| MPM BioImpact LLC | 2,388,011 | $6,208,829 | 1.61% |
| RA Capital Management | 6,144,881 | $15,976,691 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 626,810 | $1,629,706 | 0.27% |
| PFM Health Sciences, LP | 2,217,220 | $5,764,772 | 0.26% |
| Rubric Capital Management LP | 1,935,357 | $5,031,928 | 0.13% |
| Laurion Capital Management LP | 522,900 | $1,359,540 | 0.01% |
| Alyeska Investment Group, L.P. | 397,808 | $1,034,301 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 81,711 | $212,449 | 0.01% |